265 related articles for article (PubMed ID: 25716055)
21. Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan.
Uehara R; Belay ED; Maddox RA; Holman RC; Nakamura Y; Yashiro M; Oki I; Ogino H; Schonberger LB; Yanagawa H
Pediatr Infect Dis J; 2008 Feb; 27(2):155-60. PubMed ID: 18174868
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology, Treatments, and Cardiac Complications in Patients with Kawasaki Disease: The Nationwide Survey in Japan, 2017-2018.
Ae R; Makino N; Kosami K; Kuwabara M; Matsubara Y; Nakamura Y
J Pediatr; 2020 Oct; 225():23-29.e2. PubMed ID: 32454114
[TBL] [Abstract][Full Text] [Related]
23. Significant relationship between serum high-sensitivity C-reactive protein, high-density lipoprotein cholesterol levels and children with Kawasaki disease and coronary artery lesions.
Ou CY; Tseng YF; Lee CL; Chiou YH; Hsieh KS
J Formos Med Assoc; 2009 Sep; 108(9):719-24. PubMed ID: 19773210
[TBL] [Abstract][Full Text] [Related]
24. Nationwide survey on Kawasaki disease in Japan.
Yanagawa H; Kawasaki T; Shigematsu I
Pediatrics; 1987 Jul; 80(1):58-62. PubMed ID: 3601519
[TBL] [Abstract][Full Text] [Related]
25. Common variants in the CRP promoter are associated with a high C-reactive protein level in Kawasaki disease.
Kim JJ; Yun SW; Yu JJ; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Byeon JH; Sohn S; Hong YM; Jang GY; Lee JK;
Pediatr Cardiol; 2015 Feb; 36(2):438-44. PubMed ID: 25266886
[TBL] [Abstract][Full Text] [Related]
26. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
Liu R; Gao F; Huo J; Yi Q
Platelets; 2012; 23(1):11-6. PubMed ID: 21675937
[TBL] [Abstract][Full Text] [Related]
27. Elevated levels of high-sensitivity C-reactive protein and serum amyloid-A late after Kawasaki disease: association between inflammation and late coronary sequelae in Kawasaki disease.
Mitani Y; Sawada H; Hayakawa H; Aoki K; Ohashi H; Matsumura M; Kuroe K; Shimpo H; Nakano M; Komada Y
Circulation; 2005 Jan; 111(1):38-43. PubMed ID: 15611368
[TBL] [Abstract][Full Text] [Related]
28. Platelet Count Variation and Risk for Coronary Artery Abnormalities in Kawasaki Disease.
Ae R; Abrams JY; Maddox RA; Schonberger LB; Nakamura Y; Shindo A; Kuwabara M; Makino N; Matsubara Y; Kosami K; Sasahara T; Belay ED
Pediatr Infect Dis J; 2020 Mar; 39(3):197-203. PubMed ID: 31851145
[TBL] [Abstract][Full Text] [Related]
29. Nationwide Survey of Patients With Giant Coronary Aneurysm Secondary to Kawasaki Disease 1999-2010 in Japan.
Fukazawa R; Kobayashi T; Mikami M; Saji T; Hamaoka K; Kato H; Suzuki H; Tsuda E; Ayusawa M; Miura M; Ebata R; Kobayashi T; Yashiro M; Ogawa S
Circ J; 2017 Dec; 82(1):239-246. PubMed ID: 28855435
[TBL] [Abstract][Full Text] [Related]
30. Cardiac complications in children with Kawasaki disease in our own experience.
Gowin E; Małecka I; Stryczyńska-Kazubska J; Michalak M; Wysocki J; Górzna-Kamińska H
Kardiol Pol; 2016; 74(1):75-82. PubMed ID: 26202530
[TBL] [Abstract][Full Text] [Related]
31. Recurrent Kawasaki disease and cardiac complications: nationwide surveys in Japan.
Sudo D; Makino N; Nakamura Y
Arch Dis Child; 2020 Sep; 105(9):848-852. PubMed ID: 32107252
[TBL] [Abstract][Full Text] [Related]
32. Acute pericardial effusion representing the TNF-α-mediated severe inflammation but not the coronary artery outcome of Kawasaki disease.
Okada S; Hasegawa S; Suzuki Y; Matsubara T; Shimomura M; Okuda M; Ichiyama T; Ohga S
Scand J Rheumatol; 2015 May; 44(3):247-52. PubMed ID: 25351965
[TBL] [Abstract][Full Text] [Related]
33. Cardiac sequelae of Kawasaki disease in Japan over 10 years.
Hirose K; Nakamura Y; Yanagawa H
Acta Paediatr Jpn; 1995 Dec; 37(6):667-71. PubMed ID: 8775548
[TBL] [Abstract][Full Text] [Related]
34. Cardiac sequelae in recurrent cases of Kawasaki disease: a comparison between the initial episode of the disease and a recurrence in the same patients.
Nakamura Y; Oki I; Tanihara S; Ojima T; Yanagawa H
Pediatrics; 1998 Dec; 102(6):E66. PubMed ID: 9832594
[TBL] [Abstract][Full Text] [Related]
35. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease.
Mori M; Imagawa T; Yasui K; Kanaya A; Yokota S
J Pediatr; 2000 Aug; 137(2):177-80. PubMed ID: 10931408
[TBL] [Abstract][Full Text] [Related]
36. Kawasaki syndrome: the Iranian experience.
Sadeghi E; Amin R; Ajamee GH
East Mediterr Health J; 2001; 7(1-2):16-25. PubMed ID: 12596947
[TBL] [Abstract][Full Text] [Related]
37. Leukocyte counts in patients with Kawasaki disease: from the results of nationwide surveys of Kawasaki disease in Japan.
Koyanagi H; Yanagawa H; Nakamura Y; Yashiro M
Acta Paediatr; 1997 Dec; 86(12):1328-32. PubMed ID: 9475310
[TBL] [Abstract][Full Text] [Related]
38. Increasing incidence of Kawasaki disease in Japan: nationwide survey.
Nakamura Y; Yashiro M; Uehara R; Oki I; Kayaba K; Yanagawa H
Pediatr Int; 2008 Jun; 50(3):287-90. PubMed ID: 18533938
[TBL] [Abstract][Full Text] [Related]
39. Epidemiologic pictures of Kawasaki disease in Japan: from the nationwide incidence survey in 1991 and 1992.
Yanagawa H; Yashiro M; Nakamura Y; Kawasaki T; Kato H
Pediatrics; 1995 Apr; 95(4):475-9. PubMed ID: 7700743
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of coronary artery lesions on the initial echocardiogram in Kawasaki syndrome.
Baer AZ; Rubin LG; Shapiro CA; Sood SK; Rajan S; Shapir Y; Romano A; Bierman FZ
Arch Pediatr Adolesc Med; 2006 Jul; 160(7):686-90. PubMed ID: 16818833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
